Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET.

Higuchi M, Honjo H, Shigihara T, Shishido F, Suzuki H, Gotoh M.

J Cancer Res Clin Oncol. 2014 Jun 21. [Epub ahead of print]

PMID:
24952227
[PubMed - as supplied by publisher]
2.

Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.

Okuma T, Okamura T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Koyama K, Inoue K, Nakamura K, Inoue Y.

Ann Nucl Med. 2006 Feb;20(2):115-21.

PMID:
16615420
[PubMed - indexed for MEDLINE]
3.

[F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.

Donckier V, Van Laethem JL, Goldman S, Van Gansbeke D, Feron P, Ickx B, Wikler D, Gelin M.

J Surg Oncol. 2003 Dec;84(4):215-23.

PMID:
14756432
[PubMed - indexed for MEDLINE]
4.

Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning.

Blokhuis TJ, van der Schaaf MC, van den Tol MP, Comans EF, Manoliu RA, van der Sijp JR.

Scand J Gastroenterol Suppl. 2004;(241):93-7.

PMID:
15696856
[PubMed - indexed for MEDLINE]
5.

FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.

Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H.

Clin Nucl Med. 2003 Mar;28(3):192-7.

PMID:
12592125
[PubMed - indexed for MEDLINE]
6.

[18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.

Ludwig V, Hopper OW, Martin WH, Kikkawa R, Delbeke D.

Am Surg. 2003 Jul;69(7):593-8.

PMID:
12889623
[PubMed - indexed for MEDLINE]
7.

Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.

Sharma A, Lanuti M, He W, Palmer EL, Shepard JA, Digumarthy SR.

J Comput Assist Tomogr. 2013 Jan-Feb;37(1):9-14. doi: 10.1097/RCT.0b013e3182732341.

PMID:
23321827
[PubMed - indexed for MEDLINE]
8.

Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.

Langenhoff BS, Oyen WJ, Jager GJ, Strijk SP, Wobbes T, Corstens FH, Ruers TJ.

J Clin Oncol. 2002 Nov 15;20(22):4453-8.

PMID:
12431968
[PubMed - indexed for MEDLINE]
Free Article
9.

Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.

Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Iida Y, Higuchi T, Hanaoka H, Miyakubo M, Takano A, Ishikita T, Endo K.

Oncol Rep. 2007 Dec;18(6):1469-73.

PMID:
17982632
[PubMed - indexed for MEDLINE]
10.

Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study.

Bonichon F, Palussière J, Godbert Y, Pulido M, Descat E, Devillers A, Meunier C, Leboulleux S, de Baère T, Galy-Lacour C, Lagoarde-Segot L, Cazeau AL.

Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1817-27. doi: 10.1007/s00259-013-2521-9. Epub 2013 Sep 17.

PMID:
24042540
[PubMed - indexed for MEDLINE]
11.

Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results.

Travaini LL, Trifirò G, Ravasi L, Monfardini L, Della Vigna P, Bonomo G, Chiappa A, Mallia A, Ferrari M, Orsi F, Paganelli G.

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1316-22. doi: 10.1007/s00259-008-0748-7. Epub 2008 Mar 13.

PMID:
18338164
[PubMed - indexed for MEDLINE]
12.

The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.

Alafate A, Shinya T, Okumura Y, Sato S, Hiraki T, Ishii H, Gobara H, Kato K, Fujiwara T, Miyoshi S, Kaji M, Kanazawa S.

Acta Med Okayama. 2013;67(2):105-12.

PMID:
23603927
[PubMed - indexed for MEDLINE]
Free Article
13.

18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.

Okuma T, Matsuoka T, Okamura T, Wada Y, Yamamoto A, Oyama Y, Koyama K, Nakamura K, Watanabe Y, Inoue Y.

J Nucl Med. 2006 Aug;47(8):1351-8.

PMID:
16883016
[PubMed - indexed for MEDLINE]
Free Article
14.

Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation.

Deandreis D, Leboulleux S, Dromain C, Auperin A, Coulot J, Lumbroso J, Deschamps F, Rao P, Schlumberger M, de Baère T.

Radiology. 2011 Jan;258(1):270-6. doi: 10.1148/radiol.10092440. Epub 2010 Nov 2.

PMID:
21045185
[PubMed - indexed for MEDLINE]
15.

PET-CT after radiofrequency ablation of colorectal liver metastases: suggestions for timing and image interpretation.

Nielsen K, van Tilborg AA, Scheffer HJ, Meijerink MR, de Lange-de Klerk ES, Meijer S, Comans EF, van den Tol MP.

Eur J Radiol. 2013 Dec;82(12):2169-75. doi: 10.1016/j.ejrad.2013.08.024. Epub 2013 Aug 23.

PMID:
24021269
[PubMed - indexed for MEDLINE]
16.

Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience.

Kuehl H, Stattaus J, Hertel S, Hunold P, Kaiser G, Bockisch A, Forsting M.

Clin Oncol (R Coll Radiol). 2008 Apr;20(3):234-40. Epub 2007 Dec 21.

PMID:
18155453
[PubMed - indexed for MEDLINE]
17.

Single-session radiofrequency ablation of bilateral lung metastases.

Palussière J, Gómez F, Cannella M, Ferron S, Descat E, Fonck M, Brouste V, Avril A.

Cardiovasc Intervent Radiol. 2012 Aug;35(4):852-9. doi: 10.1007/s00270-011-0191-1. Epub 2011 Jun 7.

PMID:
21647807
[PubMed - indexed for MEDLINE]
18.

Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings.

Purandare NC, Rangarajan V, Shah SA, Sharma AR, Kulkarni SS, Kulkarni AV, Dua SG.

Radiographics. 2011 Jan-Feb;31(1):201-13. doi: 10.1148/rg.311105033. Review.

PMID:
21257942
[PubMed - indexed for MEDLINE]
19.

Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysis.

Zheng JH, Chang ZH, Han CB, Ma JT, Liu ZY, Lu ZM, Guo QY.

Nucl Med Commun. 2014 Apr;35(4):339-46. doi: 10.1097/MNM.0000000000000057.

PMID:
24323312
[PubMed - in process]
20.

Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.

VanSonnenberg E, Shankar S, Morrison PR, Nair RT, Silverman SG, Jaklitsch MT, Liu F, Cheung L, Tuncali K, Skarin AT, Sugarbaker DJ.

AJR Am J Roentgenol. 2005 Feb;184(2):381-90.

PMID:
15671350
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk